Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2021

View Archived Issues

"Invisible" T cells bioengineered from human iPSCs

New purine-nucleoside phosphorylase inhibitors identified at IOCB

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent 5-HT2A antagonists/DRD3 agonists

Ribon Therapeutics discovers TIPARP inhibitors

New N-acetyl-beta-D-glucosaminidase inhibitors described by Biogen

Bristol Myers Squibb identifies new TLR7/8/9 antagonists

Promising data from PDAC arm of the ongoing CANFOUR study of nadunolimab plus chemotherapy

Regulus reports updated results from phase Ib study of RGLS-4326 in ADPKD

Long-term reduced dose regimen with sargramostim shows improved safety in patients with PD

New plasma proteomic biomarkers of OCAD among patients with diabetes

HMGCR variant linked to diabetes in premature triple-vessel disease patients

FXIa inhibitor BMS-986177 well tolerated in patients with renal impairment

Pfizer evaluates 20vPnC coadministered with booster dose of COVID-19 vaccine

Pilot study evaluates NT-I7 in progressive multifocal leukoencephalopathy

Phase IIb study of aldafermin in F2/F3 NASH does not meet primary endpoint

SZN-1326 induces mucosal healing in an acute injury model of IBD

FDA approves IND for phase I trial of Scopus' CpG-STAT3siRNA

Cynata begins MEND trial of Cymerus mesenchymal stem cells in respiratory failure

Initial data reported from phase Ib study of Betalutin with rituximab in second-line FL

Nasally administered foralumab studied in secondary progressive multiple sclerosis

Kiromic submits IND for CAR T-cell therapy KB-ISM

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...